FBFS
EBS icon

First Business Financial Services’s Emergent Biosolutions EBS Stock Holding History

First Business Financial Services’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-12,590
Closed -$630K – 172
2021
Q3 		$630K Sell
12,590
-260
-2% -$15.7K 0.07% 97
2021
Q2 		$809K Buy
12,850
+2,793
+28% +$179K 0.09% 78
2021
Q1 		$934K Buy
10,057
+1,539
+18% +$158K 0.12% 56
2020
Q4 		$763K Buy
+8,518
New +$782K 0.11% 61

Other funds holding EBS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

First Business Financial Services's EBS Position: Q4 2021 in Review

First Business Financial Services sold out of Emergent Biosolutions (EBS) in Q4 2021, closing a stake of 12,590 shares — an estimated $630K sold.

First Business Financial Services first reported a position in EBS in Q4 2020 and held it in 4 quarters. The position peaked at $934K in Q1 2021. 254 funds tracked by Wall St. Rank hold EBS as of Q4 2021.

  • First Business Financial Services reported no remaining Emergent Biosolutions position as of Q4 2021 after selling out during the quarter.
  • First Business Financial Services sold 12,590 Emergent Biosolutions shares in Q4 2021, an estimated $630K.
  • First Business Financial Services first reported a position in Emergent Biosolutions in Q4 2020 and held it in 4 quarters.
  • First Business Financial Services's Emergent Biosolutions position peaked at $934K in Q1 2021.
  • 254 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q4 2021.

Based on First Business Financial Services's 13F filing for Q4 2021, filed 10 Feb 2022.